BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11741970)

  • 1. RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1.
    Adnane J; Seijo E; Chen Z; Bizouarn F; Leal M; Sebti SM; Muñoz-Antonia T
    J Biol Chem; 2002 Mar; 277(10):8500-7. PubMed ID: 11741970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities.
    Wang DA; Sebti SM
    J Biol Chem; 2005 May; 280(19):19243-9. PubMed ID: 15713677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways.
    Vasilaki E; Papadimitriou E; Tajadura V; Ridley AJ; Stournaras C; Kardassis D
    FASEB J; 2010 Mar; 24(3):891-905. PubMed ID: 19890017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells.
    Park SH; Lee SR; Kim BC; Cho EA; Patel SP; Kang HB; Sausville EA; Nakanishi O; Trepel JB; Lee BI; Kim SJ
    J Biol Chem; 2002 Feb; 277(7):5168-74. PubMed ID: 11744689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
    Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta.
    Vardouli L; Moustakas A; Stournaras C
    J Biol Chem; 2005 Mar; 280(12):11448-57. PubMed ID: 15647284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1.
    Jardine H; MacNee W; Donaldson K; Rahman I
    J Biol Chem; 2002 Jun; 277(24):21158-66. PubMed ID: 11912197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
    Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M
    Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a negative Cis-regulatory element and multiple DNA binding proteins that inhibit transcription of the transforming growth factor-beta type II receptor gene.
    Song SU; Oh IS; Lee B; Suh JK; Kim JH; Cha YD; Lee KH; Kim DH
    Gene; 2001 Jan; 262(1-2):179-87. PubMed ID: 11179682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling.
    Yoo BM; Yeo M; Oh TY; Choi JH; Kim WW; Kim JH; Cho SW; Kim SJ; Hahm KB
    Pancreas; 2005 Apr; 30(3):e71-9. PubMed ID: 15782092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota.
    Chuang LY; Guh JY; Liu SF; Hung MY; Liao TN; Chiang TA; Huang JS; Huang YL; Lin CF; Yang YL
    Biochem J; 2003 Oct; 375(Pt 2):385-93. PubMed ID: 12841849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads.
    Fu M; Zhang J; Lin Y; Zhu X; Zhao L; Ahmad M; Ehrengruber MU; Chen YE
    Biochem J; 2003 Mar; 370(Pt 3):1019-25. PubMed ID: 12457461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts.
    He T; Quan T; Fisher GJ
    Exp Dermatol; 2014 Oct; 23 Suppl 1(0 1):2-6. PubMed ID: 25234828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
    Yue J; Mulder KM
    J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells.
    Kelly D; Kim SJ; Rizzino A
    J Biol Chem; 1998 Aug; 273(33):21115-24. PubMed ID: 9694866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.
    Lebowitz PF; Davide JP; Prendergast GC
    Mol Cell Biol; 1995 Dec; 15(12):6613-22. PubMed ID: 8524226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.